Bank of Montreal’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-17,059
| Closed | -$103K | – | 5089 |
|
|
2019
Q4 | $103K | Buy |
17,059
+5,104
| +43% | +$29.5K | ﹤0.01% | 3477 |
|
|
2019
Q3 | $43K | Buy |
11,955
+705
| +6% | +$2.72K | ﹤0.01% | 3713 |
|
|
2019
Q2 | $30K | Buy |
+11,250
| New | +$33.2K | ﹤0.01% | 3943 |
|
|
2019
Q1 | – | Sell |
-1,855
| Closed | -$3K | – | 5006 |
|
|
2018
Q4 | $3K | Buy |
1,855
+920
| +98% | +$2.6K | ﹤0.01% | 4325 |
|
|
2018
Q3 | $3K | Sell |
935
-28
| -3% | -$83 | ﹤0.01% | 4297 |
|
|
2018
Q2 | $3K | Buy |
+963
| New | +$3.28K | ﹤0.01% | 4299 |
|
|
2018
Q1 | – | Sell |
-430
| Closed | -$1K | – | 4446 |
|
|
2017
Q4 | $1K | Sell |
430
-3,688
| -90% | -$13.4K | ﹤0.01% | 4134 |
|
|
2017
Q3 | $18K | Sell |
4,118
-52,597
| -93% | -$234K | ﹤0.01% | 3564 |
|
|
2017
Q2 | $260K | Buy |
56,715
+3,410
| +6% | +$13.7K | ﹤0.01% | 2523 |
|
|
2017
Q1 | $224K | Buy |
53,305
+52,875
| +12,297% | +$220K | ﹤0.01% | 2409 |
|
|
2016
Q4 | $2K | Hold |
430
| – | – | ﹤0.01% | 3920 |
|
|
2016
Q3 | $3K | Hold |
430
| – | – | ﹤0.01% | 3822 |
|
|
2016
Q2 | $3K | Sell |
430
-1,200
| -74% | -$10.3K | ﹤0.01% | 3861 |
|
|
2016
Q1 | $12K | Sell |
1,630
-8,955
| -85% | -$65.6K | ﹤0.01% | 3573 |
|
|
2015
Q4 | $114K | Buy |
10,585
+9,385
| +782% | +$85.3K | ﹤0.01% | 2716 |
|
|
2015
Q3 | $8K | Buy |
+1,200
| New | +$9.78K | ﹤0.01% | 3553 |
|
|
2014
Q3 | – | Sell |
-2,460
| Closed | -$19K | – | 4596 |
|
|
2014
Q2 | $19K | Buy |
+2,460
| New | +$9.81K | ﹤0.01% | 3619 |
|
Bank of Montreal's ACHN Position: Q1 2020 in Review
Bank of Montreal sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 17,059 shares — an estimated $103K sold.
Bank of Montreal first reported a position in ACHN in Q2 2014 and held it in 17 quarters. The position peaked at $260K in Q2 2017. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Bank of Montreal reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Bank of Montreal sold 17,059 Achillion Pharmaceuticals shares in Q1 2020, an estimated $103K.
- Bank of Montreal first reported a position in Achillion Pharmaceuticals in Q2 2014 and held it in 17 quarters.
- Bank of Montreal's Achillion Pharmaceuticals position peaked at $260K in Q2 2017.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Bank of Montreal's 13F filing for Q1 2020, filed 13 May 2020.